Company research

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) stock fundamentals

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationa

As of 2026-10-09

Exchange
XNAS
Sector
Not reported
Industry
Not reported

Read this company snapshot

Step 1 of 3

Daily valuation snapshot

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A: source evidence dated 2026-10-09.

Daily close (USD)
$432.85
Market capitalization (USD)
Not reported
Price / earnings (TTM)
Not reported
Price / book
Not reported
What you should see

The source values and product destination above identify the example to inspect.

Step 2 of 3

What business is this, and what does its dated valuation mean?

Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.

Daily valuation dataset and column definitions
What you should see

Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.

Step 3 of 3

Research BRKRP in the app

Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.

Research BRKRP in the app
What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

Company overview

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper platform for bacterial and fungal identification and establish, DNA test strips, and; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was founded in 1960 and is headquartered in Billerica, Massachusetts.

Daily valuation snapshot

See the complete daily valuation snapshot

These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing BRKRP with another company.

Scroll sideways to compare all columns. Select a heading to sort.

Daily close (USD)$432.85
Market capitalization (USD)Not reported
Price / earnings (TTM)Not reported
Price / bookNot reported

Read BRKRP's valuation metrics

  1. Company size

    Market capitalization measures the market value of the company's equity. Read it alongside revenue, earnings and debt when comparing company size.

  2. Price relative to earnings

    P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.

  3. Price relative to book equity

    Price-to-book compares market equity value with recorded book equity. Intangible assets, profitability and the company's business affect how useful the comparison is.

Research Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A with Aurora

Use the snapshot above to ask a specific question about BRKRP. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.

Continue the research

Follow BRKRP's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.